Genomic Damage and Malignancy in End-Stage Renal Failure: Do Advanced Glycation End Products Contribute?

Publisher： Karger

E-ISSN： 1423-0143|30|1|56-66

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.30, Iss.1, 2006-12, pp. : 56-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Advanced Glycation End Products in End-Stage Renal Disease and Their Removal

By  

Nephron, Vol. 87, Iss. 4, 2001-03 ,pp. : 295-303

Karger

Access to resources Recommend Favorite

Evidence for Accumulation of Advanced Glycation End Products in Acute Renal Failure

By  

Nephron, Vol. 86, Iss. 2, 2000-09 ,pp. : 186-187

Karger

Access to resources Recommend Favorite

Relation between Different Treatment Modalities and Genomic Damage of End-Stage Renal Failure Patients

By  

Kidney and Blood Pressure Research, Vol. 29, Iss. 1, 2006-06 ,pp. : 10-17

Karger

Access to resources Recommend Favorite

Effect of Dialysis on Plasma Total Antioxidant Capacity and Lipid Peroxidation Products in Patients with End-Stage Renal Failure

By  

Blood Purification, Vol. 21, Iss. 3, 2003-06 ,pp. : 209-212

Karger

Access to resources Recommend Favorite

Advanced Glycation End Products in Clinical Nephrology

By  

Kidney and Blood Pressure Research, Vol. 27, Iss. 1, 2004-02 ,pp. : 18-28

Karger

Access to resources Recommend Favorite